Dong-A ST Co Ltd banner
D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 43 850 KRW 0.8%
Market Cap: ₩410B

Relative Value

The Relative Value of one Dong-A ST Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 43 850 KRW, Dong-A ST Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Dong-A ST Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Dong-A ST Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Dong-A ST Co Ltd
KRX:170900
421.7B KRW 0.5 -188.8 13.6 129.5
US
Eli Lilly and Co
NYSE:LLY
879B USD 13.5 42.6 28.7 30.7
US
Johnson & Johnson
NYSE:JNJ
573.4B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
256.6B CHF 4.2 19.9 11.8 13.3
CH
Novartis AG
SIX:NOVN
233.8B CHF 5.4 21.6 13.3 17.1
UK
AstraZeneca PLC
LSE:AZN
222.9B GBP 5.1 29.2 16.2 22.8
US
Merck & Co Inc
NYSE:MRK
286.7B USD 4.4 15.7 9.7 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 11 8.1 9.5
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.8
P/E Multiple
Earnings Growth PEG
KR
D
Dong-A ST Co Ltd
KRX:170900
Average P/E: 22.1
Negative Multiple: -188.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42.6
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.4
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.9
14%
1.4
CH
Novartis AG
SIX:NOVN
21.6
14%
1.5
UK
AstraZeneca PLC
LSE:AZN
29.2
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
D
Dong-A ST Co Ltd
KRX:170900
Average EV/EBITDA: 43.3
13.6
167%
0.1
US
Eli Lilly and Co
NYSE:LLY
28.7
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.1
1%
8.1
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
D
Dong-A ST Co Ltd
KRX:170900
Average EV/EBIT: 103.4
129.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.7
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.3
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
CH
Novartis AG
SIX:NOVN
17.1
9%
1.9
UK
AstraZeneca PLC
LSE:AZN
22.8
21%
1.1
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
3%
3.2
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett